YubaNet.com
Saturday, November 1 2014

            We Deliver News to the Sierra
News Fire News spacer Latest News spacer Regional News spacer California News spacer USA News spacer World News spacer Op-Ed spacer Enviro News spacer Sci Tech News spacer Life spacer Odd News spacer Cartoons spacer
Features The Calendar features features Weather features Sierra NightSky features features features Road Conditions features Home spacer
CA
 

California and 23 States Reach $25 Million Settlement Against Pharmaceutical Companies that Blocked Generic Drugs


    Google+    

By: Office of the Attorney General

Oakland Jan. 7, 2010 - Attorney General Edmund G. Brown Jr. and 23 other state attorneys general today announced a $22.5 million settlement with pharmaceutical giants Abbott and Fournier after the companies "illegally blocked" cheaper generic substitutes for the cholesterol-reducing drug Tricor.

The settlement is the result of one of the country's first legal actions challenging pharmaceutical companies for "product hopping," a strategy to block generic competition by making slight changes to the formulation of a drug.

"Abbott and Fournier devised a complex scheme that illegally blocked cheaper generic drugs from entering the market," Brown said. "They used minor reformulations of the drug to delay competition and filed frivolous patent lawsuits. This scheme cost California and other states millions of dollars."

Beginning in 1998, Abbott and Fournier, two of the nation's largest pharamaceutical companies, partnered to manufacture and distribute Tricor, a cholesterol-reducing drug. Tricor's annual sales were in excess of $750 million.

By 2002, as Tricor's patents were set to expire, several drug companies sought approval from the Food and Drug Administration (FDA) to market a generic drug equivalent to Tricor. To be approved by the FDA, the generic-drug manufacturer must prove that its drug has the same active ingredients and the same labeling as the brand-name drug, in addition to being a therapeutic equivalent of the brand-name product.

Once a generic drug is approved for market, the market share for a brand-name drug like Tricor can decrease by up to 80 percent. Most states and group health plans require pharmacists to substitute the generic drug for a brand-name drug to get the cost benefit of the cheaper generic version.

Knowing generic manufacturers were attempting to enter the market, the lawsuit alleged that Abbott and Fournier devised a complex scheme to delay and prevent the approval and marketing of generic versions of Tricor. The companies made minor changes in the form and dosage strength of Tricor that did not provide any significant health benefits over previous Tricor formulations. These minor changes interfered with and delayed any FDA approval of the generics.

To further delay the process, Abbott and Fournier also filed more than a dozen lawsuits against generic drug manufacturers Teva Pharmaceuticals and Impax Laboratories because the law prohibits the FDA from approving a generic drug for 30 months after patent-infringement lawsuits have been filed. After the 30-month automatic stays expired, all of the suits were eventually dismissed.

As a result of the scheme, Abbott and Fournier recorded Tricor sales exceeding $1 billion at the expense of consumers and state governments.

Today's settlement agreement requires the companies to cease illegal efforts to block generic competition to Tricor and to pay the states approximately $22.5 million dollars. In California, the Department of General Services, Medi-Cal and the Department of Corrections will be reimbursed for overcharges.

States joining California in today's lawsuit include: Arizona, Arkansas, Connecticut, District of Columbia, Florida, Iowa, Kansas, Maine, Maryland, Minnesota, Missouri, Nevada, New York, Oregon, Pennsylvania, South Carolina, Washington, and West Virginia.

 

Help us bring you more news. Be a real reader: Support YubaNet

By submitting a comment you consent to our rules. You must use your real first and last name, not a nickname or alias. A comment here is just like a letter to the editor or a post on Facebook. Thank you.

 

Latest Headlines

CA

Field Poll: Heavy support for Prop. 1 (Water Bonds). Big swing to the no side on Prop. 45 (Health Insurance Rate Changes) and Prop. 46 (Drug Testing of Doctors/Medical Negligence Lawsuits). Continuing support for Prop. 47 (Criminal Sentences)

State Health Director Urges Californians to Get Flu Vaccine

Controller Expands Public Pay Database with Fairs & Expositions, First 5 Commissions

U.S. Attorney Names District Election Officer for November 4 General Election

High-quality drug testing helps protect the integrity of California horse racing

AG Kamala D. Harris Releases Data Breach Report; 18.5 Million Californians' Personal Information Put at Risk

New Report: Action Needed Now to Fix Climate Change Preparedness Deficit

Homeowners Are Encouraged To Prepare Their Trees for Winter Season In Case Rain Is Scarce

Napa, Solano County Residents to Receive Federal Individual, Household Aid Following South Napa Earthquake

California Dungeness Crab Season to Open Nov. 1, 2014


More

 

 

 

 

NEWS . Fire News . Latest . Regional . California . USA . World . Op-Ed . Enviro . Sci/Tech . Life . Odd News . Cartoons
FEATURES . The Calendar .Weather . Sierra NightSky. Road Conditions
YubaNet.com . Advertising. About Us . Support YubaNet . Contact Us . Terms of Use . Privacy

YubaNet.com © 1999-2014
Nevada City, California (530) 478-9600